(Q45710723)

15 December 2017

title

Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells (English)

1 reference

15 December 2017

1 reference

hepatocellular carcinoma

1 reference

Kazuyuki Ohata

1

1 reference

15 December 2017

Tatsuki Ichikawa

2

1 reference

15 December 2017

Kazuhiko Nakao

3

1 reference

15 December 2017

Masaya Shigeno

4

1 reference

15 December 2017

Daisuke Nishimura

5

1 reference

15 December 2017

Hiroki Ishikawa

6

1 reference

15 December 2017

Keisuke Hamasaki

7

1 reference

15 December 2017

Katsumi Eguchi

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

553

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

304-308

1 reference

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Activation of protooncogene c-jun by the X protein of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Short interfering RNA-directed inhibition of hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

The X protein of hepatitis B virus coactivates potent activation domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901034-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(03)01034-2

1 reference

15 December 2017

1 reference